Ascentage Pharma Group International (AAPG) Inventory (2023 - 2025)

Ascentage Pharma Group International (AAPG) has disclosed Inventory for 3 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • For Q4 2025, Inventory rose 339.34% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, up 339.34%, while the annual FY2025 figure was $4.1 million, 352.65% up from the prior year.
  • Inventory hit $4.0 million in Q4 2025 for Ascentage Pharma Group International, up from $918406.1 in the prior quarter.
  • Across five years, Inventory topped out at $4.0 million in Q4 2025 and bottomed at $918406.1 in Q4 2024.
  • Average Inventory over 3 years is $2.4 million, with a median of $2.2 million recorded in 2023.
  • Year-over-year, Inventory plummeted 59.1% in 2024 and then soared 339.34% in 2025.
  • Ascentage Pharma Group International's Inventory stood at $2.2 million in 2023, then plummeted by 59.1% to $918406.1 in 2024, then skyrocketed by 339.34% to $4.0 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $4.0 million, $918406.1, and $2.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.